Jiangsu Kanion Pharmaceutical (600557.SS) Earnings Analysis
Jiangsu Kanion Pharmaceutical (600557.SS) next reports earnings on 2026-08-14. Trailing P/E 24.79.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600557.SS next report earnings?
| Next earnings date | 2026-08-14 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.83B |
600557.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-23 | 0.18 CNY | n/a | n/a | n/a |
| 2025-10-30 | 0.1012 CNY | n/a | n/a | n/a |
| 2025-04-02 | 0.15 CNY | n/a | n/a | n/a |
| 2024-07-26 | 0.2049 CNY | n/a | n/a | n/a |
600557.SS valuation and analyst view
| Trailing P/E | 24.79 |
|---|---|
| Trailing EPS | 0.52943 CNY |
| Price / book | 1.49 |
| Dividend yield | 0.00% |
| Market cap | 7.30B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jiangsu Kanion Pharmaceutical (600557.SS)'s next earnings date?
Jiangsu Kanion Pharmaceutical is next scheduled to report on 2026-08-14 and revenue estimate of 0.83B.
Did 600557.SS beat earnings last quarter?
Consensus estimate data was not available for 600557.SS's 2026-04-23 report.
What is 600557.SS's current P/E ratio and EPS?
600557.SS trades at a trailing P/E of 24.79 on trailing EPS of 0.5294308101085824 CNY.
What do analysts rate 600557.SS?
600557.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.